SaaS for Healthcare

Software as a Service has been the dominant delivery model for healthcare technology for over a decade, powering everything from electronic health records and telehealth to revenue cycle management and patient engagement. The global healthcare SaaS market exceeded $35 billion in 2025, driven by the shift from on-premise hospital IT infrastructure to cloud-based platforms. But healthcare SaaS is now entering a period of profound disruption: the same SaaSpocalypse dynamics reshaping enterprise software are arriving in clinical settings, where AI agents are beginning to replace per-seat workflow tools that health systems pay millions for annually.

The Healthcare SaaS Stack: From EHRs to Everything

Healthcare's SaaS ecosystem is built on a foundation of electronic health record (EHR) platforms. Epic Systems dominates the U.S. hospital market with roughly 38% market share and over 305 million patient records, while Oracle Health (formerly Cerner) holds approximately 22%. These platforms are not pure SaaS—Epic still licenses on-premise deployments to large health systems—but both have moved aggressively toward cloud-hosted models. Epic's partnership with Microsoft Azure and Oracle Health's migration to Oracle Cloud Infrastructure reflect the broader industry convergence on cloud delivery.

Layered on top of EHRs is a sprawling ecosystem of point-solution SaaS vendors. Health systems typically run 50 to 100 distinct SaaS applications covering scheduling, billing, clinical communications, population health management, credentialing, supply chain, patient intake, and more. Symplr, a healthcare operations SaaS company, consolidated over 10 acquisitions into a single platform addressing workforce management, compliance, and credentialing. Veeva Systems, originally built for life sciences CRM, expanded into clinical trial management and regulatory submissions, reaching $2.8 billion in annual revenue by 2025. The sheer density of this SaaS stack—and the integration burden it creates—is precisely what makes healthcare vulnerable to the consolidation dynamics of the agentic economy.

Telehealth SaaS: Post-Pandemic Maturation

The COVID-19 pandemic transformed telehealth from a niche offering into a permanent fixture of care delivery, and the SaaS platforms powering it have matured accordingly. Teladoc Health, after its $18.5 billion merger with Livongo, struggled with post-pandemic normalization but still serves over 90 million members globally. Amwell pivoted from consumer telehealth to an enterprise platform model, licensing its Converge platform to health systems like Cleveland Clinic and Ascension for hybrid virtual-physical care delivery.

The more significant shift in 2025–2026 is the integration of telehealth into EHR-native workflows rather than standalone platforms. Epic's telehealth module now handles the majority of virtual visits at Epic-powered health systems, reducing the need for third-party telehealth SaaS. This pattern—where platform vendors absorb point-solution functionality—is accelerating across healthcare SaaS categories, echoing the broader platform consolidation dynamics described in platform economics.

Revenue Cycle Management: Healthcare's Largest SaaS Category

Revenue cycle management (RCM)—the process of managing claims, billing, coding, and collections—represents the single largest healthcare SaaS spending category, with the market exceeding $50 billion in 2025. Waystar went public in June 2024 at a $3.7 billion valuation, processing over $5 trillion in gross claims annually. R1 RCM, acquired by TowerBrook Capital and Clayton, Dubilier & Rice for $8.9 billion in 2024, operates end-to-end revenue cycle services for major health systems. Change Healthcare (now part of UnitedHealth Group's Optum) processes 15 billion healthcare transactions per year.

RCM is also where AI-driven disruption of traditional SaaS is most visible. The February 2024 cyberattack on Change Healthcare—which disrupted claims processing across one-third of U.S. healthcare transactions—exposed the fragility of centralized SaaS infrastructure. More fundamentally, AI agents are now automating prior authorization, claims denial management, and medical coding at a fraction of the cost of per-seat RCM platforms. Olive AI's pivot and eventual wind-down in 2024 was an early casualty; newer entrants like Akasa and Thoughtful AI are building AI-native RCM systems that charge per-transaction rather than per-seat, directly challenging the traditional SaaS pricing model.

The SaaSpocalypse Hits Healthcare

Healthcare SaaS is experiencing its own version of the SaaSpocalypse, though regulatory complexity has slowed the disruption compared to other industries. The pattern is clear: AI agents are commoditizing functions that healthcare SaaS vendors charge premium subscriptions for. Clinical documentation? Ambient AI scribes from Abridge and Microsoft are replacing standalone dictation SaaS. Prior authorization? AI agents now handle 60% of prior auth workflows at early-adopting health systems, displacing dedicated prior auth platforms. Patient scheduling? Conversational AI from companies like Hyro and Syllable is replacing per-seat scheduling software.

The economics are stark. A mid-sized health system might spend $2–5 million annually on SaaS subscriptions across its operational stack. An AI agent that automates the same workflows costs a fraction of that and doesn't scale with headcount. The SaaS companies most vulnerable are those selling workflow automation that AI can replicate—scheduling, coding, documentation, patient communications. The survivors will be those providing genuine data platforms, network effects (like claims clearinghouses), or regulatory infrastructure that benefits from centralization.

Yet healthcare's regulatory environment provides a partial moat. HIPAA compliance, FDA device regulations, state licensing requirements, and the sheer complexity of healthcare data interoperability create barriers that slow the Creator Era pattern of individuals building custom replacements. A startup can use an AI agent framework to build a custom CRM in a weekend; building a HIPAA-compliant clinical workflow system with HL7 FHIR interoperability, audit logging, and BAA-covered cloud infrastructure is a fundamentally different challenge. This regulatory friction means healthcare SaaS disruption will be slower but no less inevitable.

Interoperability and the FHIR Standard

The 21st Century Cures Act and its information blocking rules, fully enforced since 2024, mandate that healthcare organizations share patient data through standardized APIs. The HL7 FHIR (Fast Healthcare Interoperability Resources) standard has become the lingua franca of healthcare data exchange, and a new generation of SaaS companies has emerged to facilitate it. Health Gorilla, Particle Health (acquired by Unite Us), and 1upHealth provide FHIR-based data aggregation platforms that give SaaS applications access to patient records across disparate EHR systems.

This interoperability infrastructure is both an enabler and a threat to incumbent healthcare SaaS. On one hand, standardized APIs make it easier for new entrants to build applications that work across health systems. On the other, they reduce the data lock-in that protected legacy vendors. The convergence of FHIR APIs with AI agents creates the conditions for rapid disruption: when patient data flows freely through standardized interfaces, the barrier to building AI-native replacements for traditional SaaS drops dramatically.